Perseon Engages SunTrust Robinson Humphrey to Evaluate Strategic Options

SALT LAKE CITY, March 2, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors is exploring strategic options to enhance shareholder value. The Board has retained SunTrust Robinson Humphrey as its financial advisor to assist in this important initiative for the Company.

"We have taken definitive steps over the past few months that have positioned the company for strong future growth, and therefore we believe we have many options available to us to maximize the value of our leading microwave ablation platform," said Clint Carnell, Perseon's Chief Executive Officer. "Our Board believes now is an appropriate time to engage a leading, well-respected financial advisor to provide pragmatic, objective advice to assist us in assessing our strategic options. We remain deeply committed to our customers and peers in Life Sciences and look forward to continuing to educate the market on the clinical and economic benefits of our leading technology."

There can be no assurance that the Board's process will result in any specific action, and the Company does not intend to disclose further developments unless and until its Board approves a specific action or otherwise concludes the review of strategic options.

About Perseon

Perseon Corporation, formerly BSD Medical Corporation, is a life sciences company that develops, manufactures, markets and services groundbreaking medical systems to treat cancer using heat therapy. Perseon's MicroThermX® microwave ablation system employs precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property and distributes its products in the United States, Europe and Asia.

Forward-Looking Statements

Statements contained in this press release that are not historical facts, including statements relating to our pursuit of potential strategic opportunities, our potential growth and maximizing the value of our microwave ablation platform are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties, including the risk that for a variety of reasons we may not be able to execute on our strategic plans, and other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law.

CONTACT: Tricia Ross Financial Profiles 310-622-8226

Source:Perseon Corporation